Skip to main content
Caplight Logo









AIVF

AIVF

Private
Tel AvivHealthcare & Life Scienceshttps://aivf.co

Last Round

Series A

Jun 22, 2022

Total Funding Raised

$45M

Company Overview

AIVF operates in Healthcare & Life Sciences and is based in Tel Aviv. Its latest recorded funding round was a Series A round in June 2022.

AIVF is a healthtech company that develops AI-powered software platforms to digitize and automate IVF clinic operations, including embryo evaluation and clinical decision-making.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Vertical SaaS, Computer Vision

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

AIVF Comparables

Compare AIVF with similar companies based on industry and business-model similarity.

AIVF comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Fairtility
93%
MIM Solutions
89%
MIM Fertility
88%
Book a demo to see all comparables

For institutional investors. Book with your work email.

AIVF Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 22, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Daniella Gilboa

Co Founder And CEO, Co-Founder Chief Scientist

Founding Team

For institutional investors. Book with your work email.

AIVF Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 2, 2025

    Added Apotechconsulting, a healthcare consulting firm, as a customer.

  • Jun 22, 2022

    $25M round led by Insight Partners.

Book a demo to see all signals

For institutional investors. Book with your work email.

AIVF Filings

Explore SEC and related filing metadata, where available.

AIVF filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about AIVF's valuation, stock price, and market status.

Is AIVF a public or private company?

AIVF is a private company.

What is the current stock price of AIVF?

AIVF is a private company, so its shares have no public market price. Caplight tracks AIVF's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is AIVF worth (valuation)?

Valuation information for AIVF is not publicly available.

Can I buy AIVF stock?

AIVF shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was AIVF's last funding round?

AIVF's most recent funding round was Series A on June 22, 2022.

Who are the main investors in AIVF?

Key investors in AIVF include Insight Partners.

Will AIVF IPO soon?

No public IPO plans have been announced for AIVF.

How can I track AIVF secondary market activity?

Caplight tracks bids, offers, and trades in AIVF's shares on secondary markets.

Firmographic Details

HeadquartersTel Aviv
Employee Range12
Year Founded2018
Last FundingJun 22, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?